Lindbrook Capital, LLC Halozyme Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,416 shares of HALO stock, worth $74,764. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,416

Previous 1,703 16.85%

Holding current value

$74,764

Previous $89,000 8.99%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$51.3 - $64.42 $14,723 - $18,488	-287 Reduced 16.85%	1,416 $81,000
Q2 2024 Jul 31, 2024	BUY	$37.81 - $52.4 $6,087 - $8,436	161 Added 10.44%	1,703 $89,000
Q1 2024 Apr 25, 2024	SELL	$33.68 - $41.95 $12,798 - $15,941	-380 Reduced 19.77%	1,542 $62,000
Q4 2023 Jan 31, 2024	SELL	$33.32 - $42.1 $1,366 - $1,726	-41 Reduced 2.09%	1,922 $71,000
Q3 2023 Oct 25, 2023	BUY	$36.46 - $44.03 $3,573 - $4,314	98 Added 5.25%	1,963 $74,000
Q2 2023 Jul 28, 2023	BUY	$30.28 - $38.74 $9,326 - $11,931	308 Added 19.78%	1,865 $67,000
Q1 2023 Apr 26, 2023	SELL	$32.86 - $55.7 $11,468 - $19,439	-349 Reduced 18.31%	1,557 $59,000
Q4 2022 Jan 24, 2023	SELL	$40.06 - $59.44 $13,259 - $19,674	-331 Reduced 14.8%	1,906 $0
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $1,772 - $2,381	46 Added 2.1%	2,237 $88,000
Q2 2022 Aug 01, 2022	BUY	$37.35 - $48.3 $485 - $627	13 Added 0.6%	2,191 $96,000
Q1 2022 Apr 21, 2022	SELL	$31.97 - $41.06 $35,486 - $45,576	-1,110 Reduced 33.76%	2,178 $87,000
Q4 2021 Jan 18, 2022	BUY	$31.82 - $40.75 $103,255 - $132,233	3,245 Added 7546.51%	3,288 $132,000
Q3 2020 Nov 03, 2020	BUY	$25.74 - $29.63 $1,106 - $1,274	43 New	43 $1,000
Q2 2020 Jul 27, 2020	SELL	$16.25 - $26.81 $910 - $1,501	-56 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$13.9 - $21.83 $778 - $1,222	56 New	56 $1,000
Q1 2019 Apr 23, 2019	SELL	$13.94 - $17.58 $13,940 - $17,580	-1,000 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$13.33 - $18.66 $13,330 - $18,660	1,000 New	1,000 $14,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Halozyme Therapeutics, Inc. Transaction History